OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular matrix remodeling in the tumor immunity
Wei Du, Xueming Xia, Fan Hu, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 10

Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment
Die Lv, Yujie Fei, Hongli Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11

The importance of 3D fibre architecture in cancer and implications for biomaterial model design
J. Ashworth, Thomas R. Cox
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 461-479
Closed Access | Times Cited: 8

Dysregulated key long non-coding RNAs TP53TG1, RFPL1S, DLEU1, and HCG4 associated with epithelial-mesenchymal transition (EMT) in castration-resistant prostate cancer
Tahmineh Mehrabi, Roozbeh Heidarzadehpilehrood, Meysam Mobasheri, et al.
Advances in Cancer Biology - Metastasis (2025), pp. 100132-100132
Open Access | Times Cited: 1

Tumor secretome shapes the immune landscape during cancer progression
Jianqiang Yang, Sijia Tang, Nabil F. Saba, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1

Tenascin-C targeting strategies in cancer
Sayda Dhaouadi, Balkiss Bouhaouala‐Zahar, Gertraud Orend
Matrix Biology (2024) Vol. 130, pp. 1-19
Open Access | Times Cited: 7

Role of liposomes in chemoimmunotherapy of Breast cancer
Fatemeh Attarian, Ghazaleh Hatamian, Shamim Nosrati, et al.
Journal of drug targeting (2025), pp. 1-43
Closed Access

Comprehensive pan-cancer analysis of LAMA3: implications for prognosis and immunotherapy
Hui Huang, Wei Dong, Xuan Qin, et al.
American Journal of Translational Research (2025) Vol. 17, Iss. 2, pp. 1200-1222
Closed Access

Macrophage-derived lncRNAs in cancer: regulators of tumor progression and therapeutic targets
Muath Suliman, Raed Obaid Saleh, M Chandra, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access

Microambiente tumoral: influencia en el tratamiento del cáncer
Pablo Cabral, Ximena Camacho
SALUD MILITAR (2025) Vol. 44, Iss. 1, pp. e401-e401
Open Access

Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies
Antimo Di Spirito, Sahar Balkhi, Veronica Vivona, et al.
Exploration of Targeted Anti-tumor Therapy (2025) Vol. 6
Open Access

On investigation of complexity in extracellular matrix-induced cancer dynamics under deterministic and stochastic framework
Ranjit Kumar Upadhyay, Anjan Barman, Parthasakha Das, et al.
Nonlinear Dynamics (2025)
Closed Access

Potential therapeutic applications of medical gases in cancer treatment
Abbas Al Bazzal, Bassel H. Hoteit, Mariam Chokor, et al.
Medical Gas Research (2025) Vol. 15, Iss. 2, pp. 309-317
Closed Access

ETS-1 in tumor immunology: implications for novel anti-cancer strategies
Siyu Wang, Lei Wan, Xiao-Jun Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

3D cell culture models in research: applications to lung cancer pharmacology
Nathan Vella, Anthony G. Fenech, Vanessa Petroni Magri
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2

Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy
Baofa Yu, Shengwen Shao, Wenxue Ma
Cancer Letters (2024), pp. 217350-217350
Open Access | Times Cited: 2

Tumor-derived exosomes: unravelling the pathogenesis of pancreatic cancer with liver metastases and exploring the potential for clinical translation
Dongqi Li, Xiangyu Chu, Yongsu Ma, et al.
Cancer Letters (2024) Vol. 611, pp. 217403-217403
Closed Access | Times Cited: 2

Biomimetic Hydrogel Strategies for Cancer Therapy
Awatef M. Alshehri, Otto C. Wilson
Gels (2024) Vol. 10, Iss. 7, pp. 437-437
Open Access | Times Cited: 1

Challenges of targeting tumor microenvironment in prostate cancer
Guoliang Li, Zhenbang Chen
IntechOpen eBooks (2024)
Open Access | Times Cited: 1

Pancreatic stellate cells and the interleukin family: Linking fibrosis and immunity to pancreatic ductal adenocarcinoma (Review)
Haichao Li, Liu Dong-lian, Kaishu Li, et al.
Molecular Medicine Reports (2024) Vol. 30, Iss. 3
Open Access

Subverting Attachment to Prevent Attacking: Alteration of Effector Immune Cell Migration and Adhesion as a Key Mechanism of Tumor Immune Evasion
Marta Mastrogiovanni, Emmanuel Donnadieu, Rajiv Pathak, et al.
Biology (2024) Vol. 13, Iss. 11, pp. 860-860
Open Access

Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy
Xiaoyan Qi, Cheng Cheng, Dawei Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Page 1 - Next Page

Scroll to top